Skip to main content

DEUTSCHE BANK AG\

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 948046 FRANKFURT AM MAIN, 2M

Position in NBIX

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$48,130,546
-$4,054,948 QoQ
Shares Held
365,345
-0.7% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21.171221721934064.ToString("F0")% Shared 0.ToString("F0")% None 78.82877827806594.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
365,345 $48,130,546

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $48,130,546 365,345
2025-12-31 $52,185,494 367,944
2025-09-30 $63,283,863 450,804
2025-06-30 $51,530,131 409,978
2025-03-31 $47,218,897 426,934
2024-12-31 $63,033,241 461,782
2024-09-30 $50,446,885 437,831
2024-06-30 $59,625,838 433,107
2024-03-31 $49,631,336 359,856
2023-12-31 $44,413,131 337,076
2023-09-30 $31,196,249 277,300
2023-06-30 $33,711,211 357,489
2023-03-31 $34,435,547 340,205
2022-12-31 $81,878,506 685,520
2022-09-30 $44,231,682 416,455
2022-06-30 $43,615,863 447,434
2022-03-31 $38,763,185 413,474
2021-12-31 $35,175,462 413,003
2021-09-30 $41,208,495 429,658
2021-06-30 $41,575,393 427,203
2021-03-31 $47,516,930 488,606
2020-12-31 $42,086,294 439,085
2020-09-30 $48,944,955 508,995
2020-06-30 $110,064,008 902,164
2020-03-31 $75,492,974 872,247